Drug Discovery · Cambridge, MA · Founded 2020 · Privately Held (backing)
Operator of a biotechnology company intended to design and engineer tools to change the way diseases are cured. Parallel Bio is based in Cambridge, MA and was founded in 2020. It was valued at $71.5 million at its later-stage round in Jun 2025, the last priced event on record. It has raised $24.6 million across 2 recorded rounds; the latest was a $20 million Series A1 in Jun 2025.
PMV mark · valuation
$71.5M
Oct 2026
Priced at
its later-stage round
Jun 2025
Total raised
$24.6M
Last round
Later Stage VC (Series A1)
Jun 2025
Team — not yet on record
No current team members for Parallel Bio are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Parallel Bio with a free account
·The complete investor list: 24 names
·Watch Parallel Bio: the Monday email on marks, rounds and moves
